Patent holdings for IPC class A61K 9/12

Total number of patents in this class: 2029

10-year publication summary

228
154
180
170
150
129
132
120
108
27
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Journey Medical Corporation
96
32
Galderma Research & Development
366
24
Noxy Health Products, Inc.
39
20
VYNE Therapeutics Inc.
51
19
LEO Pharma A/S
456
16
Arcutis Biotherapeutics, Inc.
119
16
Pearl Therapeutics, Inc.
35
14
Formulated Solutions LLC
29
13
Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company
214
13
Camurus AB
148
11
Chiesi Farmaceutici S.p.A.
961
11
Theravance Biopharma R&D IP, LLC
416
11
S. C. Johnson & Son, Inc.
2784
10
Board of Regents, The University of Texas System
6065
10
Alexza Pharmaceuticals, Inc.
56
10
Cipla Limited
472
10
Mexichem Amanco Holding S.A. de C.V.
117
10
Mexichem Fluor, Sociedad Anonima de Capital Variable
202
10
Precision Dermatology, Inc.
25
10
Verona Pharma plc
54
10
Other owners 1749